Clinical Microbiology and Infection

Article	Citations
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines	697
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays	604
Abandoned trials in infection diseases and clinical microbiology: a call for action	554
Five versus seven days of nitrofurantoin for urinary tract infections in women with diabetes: a retrospective cohort study	376
Re: Primary meningococcal arthritis by a nonencapsulated Neisseria meningitidis strain	374
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	374
Impact of the COVID-19 pandemic on antibiotic prescribing in high-prescribing primary care physicians in Switzerland	299
In vivo evolution to high-level cefiderocol resistance of NDM-1–producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission	268
In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin)	238
Point-of-care ultrasound for tuberculosis and HIV—revisiting the focused assessment with sonography for HIV-associated tuberculosis (FASH) protocol and its differential diagnoses	180
Title Page	174
A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management	161
Outside Front Cover	156
Cefiderocol susceptibility testing: the challenge of disc diffusion	146
Foot infection of Mycobacterium smegmatis	142
Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients	141
Optimising vaccination strategies to prevent invasive pneumococcal disease in the elderly. Which vaccine should come first?	136
Revisiting diagnostics: high priority tuberculosis diagnostic tests that fill an unmet need: what we need and what we do not need	135
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	124
Performance of molecular tests for diagnosis of bloodstream infections in the clinical setting: a systematic literature review and meta-analysis	122
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)	122
Revisiting diagnostics: syndromic PCR-based testing beyond its approval and what we need instead	117
Characteristics and long-term prognosis of Danish residents with a positive intrathecal antibody index test for herpes simplex virus or varicella-zoster virus compared with individuals with a positive	109
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	107
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	106

Analytical interference with most current commercial HIV molecular assays in patients treated by idecabtagene vicleucel, a recently approved lentivirus-based chimeric antigen receptor T-cell therapy	104
Rituals and behaviours in the operating theatre and preventing infection. Using the evidence and consensus opinion to provide practical advice	103
Intravenous metronidazole for fulminant Clostridioides difficile infection	102
Evidence-based dosing of convalescent plasma for COVID-19 in future trials	102
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area	100
Treatment of Coxiella burnetii endocarditis with hydroxychloroquine. Is it evidence-based?	97
“Unite for safety – clean your hands”: the 5 May 2022 World Health Organization SAVE LIVES: Clean Your Hands campaign	97
Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al	90
Re: ‘Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales’ by Molina et al.	86
The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis	85
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19	84
Gut microbiome diversity and composition in individuals with and without extended-spectrum β-lactamase-producing Enterobacterales carriage: a matched case–control study in infectious diseases departme	84
Development and validation of a novel death risk stratification scale in patients with hemorrhagic fever with renal syndrome: a 14-year ambispective cohort study	83
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	82
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	82
The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients	81
Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?	78
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing	76
Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination	75
Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.	72
Detection of Borrelia burgdorferi sensu lato by proteomics: a complementary diagnosis tool on erythema migrans biopsies	71
How to verify and validate a clinical microbiology test before it can be used in routine diagnostics: a practical guide	70
Exploring the limits of interferon-γ releasing assay screening in large-scale populations	70
Clinical Microbiology and Infection will recognize excellent research by early-career scientists	70
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?	69
Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 in older Singaporeans: author's response	68
Methicilin-resistant Staphylococcus aureus in the community—time to take action	67
Revisiting diagnostics: the reliability of culture-independent detection of microbial pathogens by DNA sequencing needs improvement	65
Guideline-based intervention improves the quality of antibiotic allergy registration in a hospital setting	63
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	63
Thank you to our peer-reviewers: CMI 2022	62
Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT)	62
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections	60
Title Page	59
Publishing Information	58
Prophylaxis for COVID-19: a systematic review	57
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	56
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	55
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial	54
Resurgence of syphilis in 2022 amongst heterosexual men and women in Osaka, Japan	53
Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion	53
COVID-19 associated mucormycosis: a life-threatening complication in patients admitted with severe to critical COVID-19 from Pakistan	53
Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile	53
Selective reporting of antibiotic susceptibility testing results: less is more	52
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study	52
Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al	52
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.	51
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	51
A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality	51
The prognostic value of serological titres in chronic Q fever: treat the patient, not the laboratory data	51

Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19	50
Expanding evidence for shortened treatment of latent tuberculosis infection: progress, not perfection	50
Occurrence of in vivo carbapenem-resistant Campylobacter coli mediated by porA point mutation and overexpression of blaOXA-489 under meropenem treatment	50
Lower (1,3)-β-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains: author's response	50
Trends in antimicrobial resistance of bacterial isolates in China, 2014 to 2022	50
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	50
Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria	49
Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitis	49
Early switch from intravenous to oral anti-microbial therapy in infectious diseases	47
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response	47
Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weight analysis in two large, prospectively evaluated coho	47
Analyzing COVID-19 vaccine efficacy in vulnerable communities: efforts beyond addressing vaccine inequity	47
A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis	46
Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using Fastidious Anaerobe Agar (FAA): a development study using Bacteroides species	46
Clinical microbiology and infection: an open call for editorial interns	46
How to interpret and use COVID-19 serology and immunology tests	46
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort	45
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study	45
Use of artificial intelligence for tailored routine urine analyses	45
Revisiting diagnostics: rapid diagnosis of neurological infections	44
Guidance on reporting the use of natural language processing methods	44
Procalcitonin in acute exacerbation of chronic obstructive pulmonary disease: can fresh evidence tip the scales?	44
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response	44
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study	43
Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials	43
The COVID-19 vaccine health pass fraud in France	43
Use of biomarkers to individualize antimicrobial therapy duration: a narrative review	42
Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship	42
Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis	42
Re: ‘Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe’ by Lange et al.	42
Appeal from the European tuberculosis reference laboratory network (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria	41
COVID-19 in special populations	40
Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized co	40
Searching high and low: call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children–part one	40
Real-time dermoscopy of numerous mites crawling on the crusted scabies	40
Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.	40
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples	40
Omicron variant: assessing the duration of viral shedding and its implications	39
Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.	39
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield	39
Who should receive oral antiviral therapy for severe acute respiratory syndrome coronavirus 2 infection in the omicron era? Choose wisely	39
A man with a prepared mind – in commemoration of the bicentenary of the birth of Louis Pasteur 1822 - 2022	39
Re: ‘Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses’ by Braun et al	39
Compromised access to antibiotics: addressing pediatric challenges in availability and responsible use	38
Ceftaroline for bloodstream infections caused by methicillin-resistant Staphylococcus aureus: a multicentre retrospective cohort study	38
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	38
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments	38
Comparison of four assays for human papillomavirus detection in the anal canal	37
Publishing Infectious Disease Research from Low- and Middle-Income Countries	37
In vitro susceptibility of fosfomycin in Aerococcus spp. isolated from urine samples	36
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	36
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission	36
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort	36
Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia	36
Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies	36
Impact of susceptible, increased exposure, a new definition of the former intermediate susceptibility category, introduced by the European Committee for Antimicrobial Susceptibility Testing on antimic	35
Acceptance of coronavirus disease 2019 vaccine among health-care personnel in India: a cross-sectional survey during the initial phase of vaccination	35
Antimicrobial stewardship challenges in extracorporeal membrane oxygenation	35
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	35
A novel multiplex real-time polymerase chain reaction for the molecular diagnosis of metacestode infections in human patients	35
Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species	34
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19	34
More evidence needed before upper respiratory tract point-of-care microbiological testing for respiratory infections is used in primary care	33
Risk of cardiac conduction disorders, and pacemaker implantations among individuals tested for serum Borrelia burgdorferi antibodies, a nationwide, matched, population-based cohort study	33
Performance of Xpert Ultra nasopharyngeal swab for identification of tuberculosis deaths in northern Tanzania	33
Limitations of classification and regression tree analysis in vancomycin exposure–response relationship studies: insights from data simulation	33
Clinical phage microbiology: a narrative summary	33
The world health organization pandemic agreement draft: considerations by the European Society of Clinical Microbiology and Infectious Diseases Emerging Infections Task Force	33
Mission (im)possible: elimination of tuberculosis	33
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	33
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value	32
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?	32
Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study	32
Scientific misconduct in infectious diseases—European Society of Clinical Microbiology and Infectious Diseases survey	32
Elevated body mass index is associated with an increased risk of infectious disease admissions and mortality: a mendelian randomization study	32
Quantifying the impact of COVID-19-related restrictions on antibiotic resistance	32
Which are the best coronavirus disease 2019 vaccines?	31
ARCHITECT Chagas® as a single test candidate for Chagas disease diagnosis: evaluation of two algorithms implemented in a non-endemic setting	31
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections	31
Persistence of the neutralizing antibody response after SARS-CoV-2 infection	31

Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study	31
Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage	31
Re: Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil by Ranzani et al.	31
Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy	31
Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study	30
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial	30
Bacterial load in cerebrospinal fluid predicts unfavourable outcome in pneumococcal meningitis: a prospective nationwide cohort study	30
Quantifying the long-term effects of measles infection—a retrospective cohort study	30
Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial	30
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins	30
Attributable mortality of antibiotic resistance in gram-negative infections in the Netherlands: a parallel matched cohort study	30
Diagnostic accuracy of rapid antigen tests in cerebrospinal fluid for pneumococcal meningitis: a systematic review and meta-analysis	30
Humoral serological response to the BNT162b2 vaccine after allogeneic haematopoietic cell transplantation	29
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir	29
Value of lipocalin 2 as a potential biomarker for bacterial meningitis	29
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors–a cross-sectional study in seven German university hospitals from 2014 to 2018	29
Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance	29
Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis	29
Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients	28
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay	28
A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways	28
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine	28
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study	28
The impact of social restrictions on the incidence and microbiology of peritonsillar abscess: a retrospective cohort study	28
Tuberculosis treatment monitoring tests during routine practice: study design guidance	28
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	28
Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study	27
First detection of the emerging vancomycin-resistant Enterococcus faecium vanA-ST1299-CT1903 in Austria	27
‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply	27
Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting	27
Follow-up blood cultures do not reduce mortality in hospitalized patients with Gram-negative bloodstream infection: a retrospective population-wide cohort study	27
The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research	27
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis	27
Sample pooling: burden or solution?	27
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	27
Vaccines alone will not prevent COVID-19 outbreaks among migrant workers—the example of meat processing plants	27
Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update	27
Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis	26
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain	26
External validation of WGS-based antimicrobial susceptibility prediction tools, KOVER-AMR and ResFinder 4.1, for Escherichia coli clinical isolates	26
Update on SARS-CoV-2 seroprevalence: regional and worldwide	26
Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model	26
The Shorter Is Better movement: past, present, future	26
Viral dynamics of SARS-CoV-2 in immunocompromised patients	25
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability	25
Detection of Treponema pallidum DNA for diagnosis, resistance identification, and treatment outcome prediction in early syphilis among men who have sex with men	25
Which trial do we need? Mannitol therapy in hospitalized adult patients with tick-borne encephalitis and brain oedema: a double-blind placebo-controlled multicentre randomized trial	25
Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management	25
Characterizing the inclusion of pregnant and breastfeeding people in infectious diseases randomized controlled trials: a targeted literature review	25
A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients	25
COVID-19 vaccination in Israel	25
Information technology aspects of large-scale implementation of automated surveillance of healthcare-associated infections	25
Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway	25
Corrigendum to “Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations” [Clin Microbiol and Infect 26 (1) (2020) 60–70]	25
External validation of the PRIORITY model in predicting COVID-19 critical illness in vaccinated and unvaccinated patients	25
Association between male circumcision and human papillomavirus infection in males and females: a systematic review, meta-analysis, and meta-regression	24
Re: ‘Cost–benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for Vancomycin’ by Lee et al.	24
Update on the diagnosis of tuberculosis	24
Clinical and laboratory features of Strongyloides stercoralis infection at diagnosis and after treatment: a systematic review and meta-analysis	24
Minimizing nephrotoxicity during multidrug-resistant tuberculosis treatment by the stepwise de-escalation of second-line injectables dosing intervals	24
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?	23
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme	23
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses	23
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	23
Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients	23
Taking the patient pulse: gauging outcomes important to patients for bloodstream infection trials	23
Can we use viral receptor mapping and particle deposition models to predict the clinical severity of novel airborne pathogens?	23
Comparison of three sample types for performing LDBio Aspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis	23
Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis	23
Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?	22
Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial	22
Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B	22
Re: HANCEK infective endocarditis by Webb et al.	22
Re: Surveillance of Mycobacterium tuberculosis drug resistance and epidemiology in Southwest China, a China CDC pilot study	22
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience	22
A prenatal testing program among future fathers in a Paris metropolitan area maternity reveals a high proportion of undiagnosed and not linked to care chronic viral hepatitis B	22
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	22
Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children	22
Encephalitis: intersections between infections and autoimmunity	22
The risk of drug-induced liver injury associated with flucloxacillin: a nationwide, entropy-balanced cohort study	22
Re: “HANCEK” infective endocarditis: a case for including Neisseria elongata in the HACEK group	22
Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections	22
The ESCMID ethics advisory committee (EEAC): purpose and challenges	21
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	21
Dynamics and predisposition of respiratory viral co-infections in children and adults	21
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	21
Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey	21
Antibiotic use from formal and informal healthcare providers in the Democratic Republic of Congo: a population-based study in two health zones	21
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections	21
Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort study	21
Candidate anti-tuberculosis medicines and regimens under clinical evaluation	21
Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers	21
PRAISE: providing a roadmap for automated infection surveillance in Europe	20
Management of uncomplicated urinary tract infection in the post-antibiotic era: select non-antibiotic approaches	20
Urinary tract infections in pregnancy	20